Who won: NEXT GENERATION SEQUENCING PANEL FOR FAMILIAL HYPERCHOLESTEROLEMIA AND WHOLE EXOME SEQUENCING LIBRARY PREP SOLUTION

About this contract

The contract is for the provision of a Next Generation Sequencing (NGS) panel, associated reagents, technical support, training and related services to support diagnostic testing for Familial Hypercholesterolaemia (FH) within the All Wales Genomics Laboratory. Nonacus is the sole supplier capable of providing the required proprietary panel and associated services, which have been extensively validated within the existing diagnostic pathway. The solution is fully compatible with current laboratory infrastructure and includes ongoing technical support, quality assurance and contingency arrangements to support continuity of service delivery. The service supports approximately 600 diagnostic tests per annum, including initial and cascade testing, as part of the nationally commissioned All Wales Familial Hypercholesterolaemia service.

Who won contracts like this

• ✓Answer against the marking scheme, not the question text — Cardiff and Vale University Health Board scores each response, so map your evidence to the published criteria and weightings.
• ✓Lead with evidenced capability and social value — for public sector work these usually outweigh price.
• ✓Show recent, comparable delivery: name similar public sector contracts you've delivered for public bodies, with measurable outcomes.
• ✓This one's been awarded — but Cardiff and Vale University Health Board retenders on a cycle. Get matched the day the next one lands and start your draft early.

BidWriter drafts your responses from your company profile, scores them against the marking scheme, and tracks your whole pipeline. Free to start — no card needed.

Related resources

Similar contracts